Interpretative strategies for lung function tests

By R. Pellegrino, G. Viegi, V. Brusasco, R. Crapo, F. Burgos, R. Casaburi, A. Coates, C. P. Grinten, P. Gustafsson, J. Hankinson and 8 more. European Respiratory Journal, 2005

5,888 citations recorded by the source corpus.

Subfields: Pulmonary and Respiratory Medicine

View Paper: https://www.semanticscholar.org/paper/db6518d167022113e9edd298226b9bfbdbc77ef7

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Pulmonary and Respiratory Medicine

Citations in the corpus

ERS/ATS technical standard on interpretive strategies for routine lung function tests (2021, methodology): “, > 200 ml AND > 12 % increase in FEV1 and/or FVC) (3).”
A summary of the new GINA strategy: a roadmap to asthma control (2015, background): “…expiratory volume in 1 s (FEV 1 ) (up to 12% week to week and 15% year-to-year in healthy individuals, and higher in patients with airway disease [28]) substantially limits its utility for adjusting treatment, so once the diagnosis of asthma has been confirmed, spirometry is primarily useful for…”
Reference ranges for spirometry across all ages: a new approach. (2008, methodology): “, 12%), is unlikely to be appropriate (3).”
General considerations for lung function testing (2005, methodology): “For a full account of interpretive strategies, the ATS and ERS have now revised [ 44 ] their previous statements [39, 41– 43].”
Interstitial lung disease guideline (2008, background): “By contrast, a minimum change of 15% is required in TLCO, a less reproducible variable.(113) Thus, serial FVC is likely to be more sensitive to change than serial TLCO.”
Clinical Significance of Symptoms in Smokers with Preserved Pulmonary Function (2016, neutral): “(%) 27/199 (14) 16/423 (4) 37/425 (9) 11/336 (3) 24/626 (4)”
Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. (2007, methodology): “Spirometry measurements are evaluated by comparison with reference values (65) based on age, height, sex, and race (use appropriate reference values; e.”
Global Initiative for Asthma Strategy 2021: Executive Summary and Rationale for Key Changes (2021, neutral): “Lung function at individual visits is of limited use for guiding treatment because of its large (up to 20%) visit-to-visit variation (10).”
Editorial: Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2023 Guidelines for COPD, Including COVID-19, Climate Change, and Air Pollution (2023, neutral): “Результаты спиро метрии оценивают путем сравнения с должными величи нами [122] для данного возраста, роста, пола и расы.”